Medicine

When general population speak of modern medicine, precision plays one of the most crucial roles and people’s lives are directly dependent on it. Hence, any researches pertaining to medicine are required to comply with the top standards. The issue nowadays is that any conclusions of researches can be shared online and used as a reference without being thoroughly verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and tried to generate an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to verify publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores higher than 10

Drug pricing is a big issue in the news, and there is continued controversy surrounding the major differences in patented cancer drug prices around the world. However, the patterns of affordability of these drugs are poorly understood. And although cancer care is undergoing a revolution with the arrival of new therapies such as immunotherapy, monoclonal antibodies, and targeted therapy, prices for cancer drugs vary widely. “Oncotarget” A recent study in Oncotarget, 2017, Vol. 8, Issue 42, by Jonathon Clark, Daniel A. Goldstein and others entitled “A global comparison of the cost of patented cancer drugs in relation to global differences in wealth” compared patterns of affordability of cancer drugs in Australia, China, India, Israel, South Africa, the United Kingdom, and the United States to assess whether affordability corresponded to other economic indicators. The researchers considered many factors in determining patterns of affordability, including: Oncotarget International diffe

When public discuss today’s medicine, precision plays one of the most crucial roles and human lives are literally dependent on it. Hereby, any researches pertaining to medicine are necessary to comply with the top standards. The issue today is that any conclusions of researches can be published online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this problem and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been established back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a full publications list with corresponding scores above 100 as well a

When people discuss today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Hereby, any researches related to medicine are necessary to comply with the top standards. The issue nowadays is that any recommendations of researches can be published online and used as a reference without being thoroughly checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality measure. That assists both readers and authors to validate publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with respective scores higher than 100 as

There are more than 800,000 active podcasts available for listening today, and that number is projected to continue to rise as starting a podcast has become easier than ever before. Obviously, with this many podcasts to choose from, it’s becoming very difficult for podcast listeners to weed out quality listens from the podcasts that aren’t worth their time. In order to help listeners find the best podcast based on their interests, the cloud-based podcast app player.fm recently published its recent “Best-of lists” and named the open-access biomedical journal Oncotarget’s podcast in the top-ten in a list of “50 open-access podcasts for 2020”. The honor comes from the Journals’ incredible reporting and coverage on cancer research. Chicago hospital Houston hospital Phoenix hospital The Oncotarget podcast show has been informing listeners on the latest news from scientists since the fall of 2016. Past podcasts have included end-to-end readings of published papers as well as press rel

When people mention today’s medicine, accuracy plays one of the most crucial roles and human lives are directly dependent on it. Likewise, any researches related to medicine are necessary to comply with the highest standards. The challenge today is that any conclusions of researches can be shared online and used as a reference without being adequately verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is based on Altmetric scores that are used as a quality indicator. That helps both readers and authors to verify publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with respective scores higher than 100 as well as repo

In this study, researchers performed the first comprehensive analysis of the current landscape of clinical trials for pancreatic cancer to better understand the near future of potential new therapies. 3D illustration of Pancreas - part of digestive The vast scope of studies currently underway around the world sometimes makes it difficult to determine the current state of research in a particular field. Researchers based out of Cleveland, Ohio, and Charlotte, North Carolina, found this to be especially true when it comes to pancreatic cancer research. Published in Oncotarget, these researchers authored a paper meticulously detailing the current state of research in pancreatic ductal adenocarcinoma (PDAC). Chicago hospital Houston hospital Phoenix hospital Pancreatic Cancer Research Funding The National Institutes of Health (NIH) allocates somewhere around $6 billion annually to fund cancer research and, of these funds, more than $100 million is dedicated solely to the study of p